Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Mexico for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Mexico only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Mexico (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Katherine Sanchez (NPI 1558740647)

Field	Value
Entity Type	Individual
Organization	Katherine Sanchez
Address	4901 Lang Ave Ne
City	Albuquerque
State	NM
ZIP	87109
Taxonomy	Medical Oncology Physician
NPI Enumerated	May 22, 2015

Payer Source	Total Paid
Medicare	$562.4K
Medicaid	$0

Key Findings

Revenue concentration is extremely high: this provider’s top three Medicare revenue drivers (J9271, 99215, J0897) together account for 82.8% of total Medicare revenue, while total Medicare revenue across the provider’s lifetime is $562.4K. J9271 alone brings in $361.2K (64.9% of the provider’s Medicare revenue), followed by 99215 with $59.9K (10.8%) and J0897 with $40K (7.2%).

The code mix reflects an infusion-centered oncology practice with substantial high-cost immunotherapy utilization and frequent complex office management encounters. J9271 (pembrolizumab) is the dominant revenue source at $361.2K, supported by chemotherapy administration codes such as 96413, 96401, 96417 and infusion management codes like 96365 and 96367, indicating on-site systemic therapy delivery and associated procedural throughput.

Payer mix is effectively single-payer Medicare: the provider reports $562.4K in total Medicare revenue and has no Medicaid billing on file (none). This concentration means the practice’s revenue profile and risk are focused on Medicare reimbursement and utilization patterns rather than a mixed Medicare/Medicaid patient base.

Competitive standing is mixed across service lines: the provider is an extreme outlier on office E/M volume for 99215 (ranks #2299 of 145531 nationally, 98th percentile; extreme outlier), indicating far higher-than-typical high-complexity visit volume nationally, while J9271 ranks #1358 of 1841 (25th percentile; typical, unremarkable volume) and J0897 ranks #5727 of 10057 (42th percentile; typical, unremarkable volume), showing routine participation in drug delivery but not national dominance for those medications.

Operationally, the practice shows high claim counts for several low-dollar supply/drug codes that nevertheless contribute materially when aggregated. For example, J1439 appears as 14.3K claims at $1 avg paid/claim yielding $14.3K revenue (2.6% of Medicare revenue), and J0640 has 420 claims at $3 avg paid/claim yielding $1.3K revenue, consistent with frequent administration of supportive agents and infusion supplies.

Presence of chronic care and remote-management codes suggests ancillary care functions alongside infusion oncology: 99491 (18 claims, $65 avg, $1.2K revenue; ranks #1111 of 1258, 10th percentile) and 99490 (20 claims, $47 avg, $940 revenue; ranks #15521 of 16216, 4th percentile) plus phone/televisit codes 99441/99442 indicate some engagement in chronic care management and virtual/phone follow-up, though volumes are modest relative to nationwide peers.

Revenue concentration around a single high-cost oncology drug (J9271 at $361.2K, 64.9% of Medicare revenue) creates material exposure: changes in utilization patterns, clinical guidelines, or Medicare reimbursement for pembrolizumab could substantially affect this provider’s Medicare revenue. The practice’s financial profile is therefore sensitive to oncology drug mix and reimbursement shifts rather than broad-based E/M diversification.

Tenure is established but not long-tenured: NPI enumerated 2015-05-22 (~11 years ago), indicating roughly a decade of billing history under this NPI. Combined with the heavy reliance on infusion codes and high-complexity visits, the billing footprint is that of an established outpatient oncology clinician with a mature, Medicare-focused practice pattern.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

40 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	8,400	$40	$361.2K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	460	$130	$59.9K
J0897	Injection, denosumab, 1 mg	2,220	$20	$40K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	220	$100	$20.4K
J1439	Injection, ferric carboxymaltose, 1 mg	14,250	$1	$14.3K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	60	$160	$9.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	100	$80	$8.5K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	60	$130	$7.9K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	220	$20	$4.7K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	80	$50	$4.3K

Showing 1–10 of 40

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 40 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Mexico Distribution

Katherine Sanchez — 1 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Mexico

Full comparison — all codes billed, vs. state median

40 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	8	10	9,400	$40	$469.6K
J0897	31	50	3,150	$20	$113.2K
J9217	23	20	180	$130	$23.4K
J1439	12	10	25,500	$1	$23.1K
96413	16	40	170	$90	$17.7K
99214	1,278	2,700	90	$70	$12.9K
99490	137	140	100	$40	$8.9K
99215	18	960	40	$110	$7.8K
99213	1,977	2,440	60	$50	$7.3K
99223	405	490	30	$130	$7.3K

Showing 1–10 of 40

Related Providers

Other providers that share a Tax Identification Number (TIN) with Katherine Sanchez, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Baylor College Of Medicine	TX	Family Medicine Physician	$0	$18.1M
New Mexico Oncology Hematology Consultants, Ltd.	NM	Hematology & Oncology Physician	$0	$4.2M
Gregg Franklin	NM	Radiation Oncology Physician	$2.5M	$0
Scott Stoerner	NM	Rheumatology Physician	$1.5M	$0
Shaya Ansari	NY	Diagnostic Radiology Physician	$1.5M	$1K
Pranshu Bansal	AZ	Hematology & Oncology Physician	$1.4M	$0
Ronald Kubica	NM	Medical Oncology Physician	$1M	$0
Huiping Xu	TX	Psychiatry Physician	$998.1K	$2.4K
Annette Fontaine	NM	Medical Oncology Physician	$918.5K	$0
Brigid Marshall	TN	Retina Specialist (Ophthalmology) Physician	$909.4K	$0

Nearby Providers

Other providers in the same ZIP code as Katherine Sanchez, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Presbyterian Healthcare Services	NM	Internal Medicine Physician	$0	$240.8M
Heritage Home Healthcare Services, Inc.	NM	Home Health Agency	$0	$141.5M
Home Medical Equipment Specialists LLC	NM	Durable Medical Equipment & Medical Supplies	$0	$100M
The New Beginnings LLC	NM	Adult Day Care Clinic/Center	$0	$85.1M
We Care Agency, Inc.	NM	In Home Supportive Care Agency	$0	$60.1M
Lovelace Health System, LLC	NM	General Acute Care Hospital	$0	$57.7M
Adelante Development Center, Inc.	NM	Personal Care Attendant	$0	$57M
Eye Associates Of New Mexico Ltd	NM	Ophthalmology Physician	$0	$46.9M
Southwest Labs LLC	NM	Clinical Medical Laboratory	$1.1M	$41.5M
Southwest Medical Associates, LLC	NM	General Practice Physician	$0	$41.4M

Katherine Sanchez — Billing Profile & Reimbursement Data

Sign up for Katherine Sanchez — Billing Profile & Reimbursement Data policy alerts

Katherine Sanchez — Billing Profile & Reimbursement Data

Sign up for Katherine Sanchez — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References